As of May 29
| +0.16 / +1.91%|
The 8 analysts offering 12-month price forecasts for BioDelivery Sciences International Inc have a median target of 17.50, with a high estimate of 21.00 and a low estimate of 12.00. The median estimate represents a +105.40% increase from the last price of 8.52.
The current consensus among 8 polled investment analysts is to Buy stock in BioDelivery Sciences International Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.